Literature DB >> 34676436

Individualized glycemic management for critically ill patients.

Tomoya Okazaki1, Akihiko Inoue2, Yasuhiro Kuroda3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34676436     DOI： 10.1007/s00134-021-06559-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Individualized glycaemic management for critically ill patients. Authors' reply.

Authors:  Julien Bohé; Jean-Charles Preiser
Journal:  Intensive Care Med       Date:  2021-11-09       Impact factor: 17.440

2.  Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial.

Authors:  Lalantha Leelarathna; Shane W English; Hood Thabit; Karen Caldwell; Janet M Allen; Kavita Kumareswaran; Malgorzata E Wilinska; Marianna Nodale; Jasdip Mangat; Mark L Evans; Rowan Burnstein; Roman Hovorka
Journal:  Crit Care       Date:  2013-07-24       Impact factor: 9.097
  3 in total
  2 in total

1.  Individualized glycaemic management for critically ill patients. Authors' reply.

Authors:  Julien Bohé; Jean-Charles Preiser
Journal:  Intensive Care Med       Date:  2021-11-09       Impact factor: 17.440

2.  Association between time in range of relative normoglycemia and in-hospital mortality in critically ill patients: a single-center retrospective study.

Authors:  Tomoya Okazaki; Akihiko Inoue; Takuya Taira; Shun Nakagawa; Kenya Kawakita; Yasuhiro Kuroda
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.